Analysis of germline variants in pediatric patients diagnosed with desmoid tumors and nuchal-type fibromas.

Desmoid tumor (DT) germline next generation sequencing (NGS) nuchal-type fibroma

Journal

Translational pediatrics
ISSN: 2224-4344
Titre abrégé: Transl Pediatr
Pays: China
ID NLM: 101649179

Informations de publication

Date de publication:
18 Sep 2023
Historique:
received: 02 02 2023
accepted: 27 07 2023
medline: 10 10 2023
pubmed: 10 10 2023
entrez: 10 10 2023
Statut: ppublish

Résumé

Desmoid tumor (DT) is a fibroblastic proliferation arising in soft tissue characterized by localized infiltrative growth with an inability to metastasize but with a tendency to recurrence. Nuchal-type fibromas are benign soft tissue lesions that are usually developed in the posterior neck. The development of these neoplasms can be associated with a hereditary cancer predisposition syndrome, mainly familial adenomatous polyposis (FAP) syndrome caused by

Identifiants

pubmed: 37814722
doi: 10.21037/tp-23-60
pii: tp-12-09-1715
pmc: PMC10560355
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1715-1724

Informations de copyright

2023 Translational Pediatrics. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-60/coif). The authors have no conflicts of interest to declare.

Références

J Pediatr Hematol Oncol. 2016 Jul;38(5):e154-7
pubmed: 26840078
Neuro Oncol. 2020 Jan 11;22(1):128-138
pubmed: 31504825
Science. 1998 Apr 24;280(5363):596-9
pubmed: 9554852
J Cutan Pathol. 2020 Aug;47(8):734-741
pubmed: 32187703
Clin Gastroenterol Hepatol. 2020 Aug;18(9):1949-1960
pubmed: 32147591
Orphanet J Rare Dis. 2013 Apr 05;8:54
pubmed: 23561487
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2):
pubmed: 30696621
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cancer. 2022 Aug 15;128(16):3027-3040
pubmed: 35670122
Surg Oncol. 2007 Aug;16(2):131-42
pubmed: 17719772
Eur J Cancer. 2020 Mar;127:96-107
pubmed: 32004793
Fam Cancer. 2017 Jan;16(1):67-71
pubmed: 27573199
Am J Surg Pathol. 2000 Nov;24(11):1563-7
pubmed: 11075861
Skeletal Radiol. 2010 Feb;39(2):175-82
pubmed: 19768644
Eur J Surg Oncol. 2016 Jul;42(7):1071-83
pubmed: 26965303
Bull Cancer. 2016 Feb;103(2):199-209
pubmed: 26805944
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50
pubmed: 7708772
Oncol Lett. 2019 Dec;18(6):6443-6450
pubmed: 31807167
Mol Biol Rep. 2022 May;49(5):3823-3837
pubmed: 35142982
Pathol Int. 2004 Jul;54(7):523-6
pubmed: 15189507
Am J Med Genet A. 2005 Apr 15;134A(2):212-4
pubmed: 15690400
Dis Colon Rectum. 2009 Apr;52(4):742-5
pubmed: 19404084
Tumori. 2021 Dec;107(6):NP73-NP76
pubmed: 33849326
Eur J Hum Genet. 2015 May;23(5):715-8
pubmed: 25074465
Dis Colon Rectum. 2018 Sep;61(9):1073-1079
pubmed: 30086056
Am J Surg Pathol. 1995 Mar;19(3):313-7
pubmed: 7872429
Int J Cancer. 2001 Mar 20;95(2):102-7
pubmed: 11241320
Int J Oncol. 2001 May;18(5):1017-22
pubmed: 11295050
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11365-70
pubmed: 11027336
J Mol Diagn. 2021 Nov;23(11):1452-1459
pubmed: 34454113
In Vivo. 2020 Sep-Oct;34(5):2217-2223
pubmed: 32871744
Hered Cancer Clin Pract. 2017 Mar 16;15:5
pubmed: 28331556
Oncologist. 2011;16(5):682-93
pubmed: 21478276
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):428-441
pubmed: 30585891
Dis Colon Rectum. 2015 Apr;58(4):444-8
pubmed: 25751801
Am J Gastroenterol. 2006 Feb;101(2):385-98
pubmed: 16454848
Int J Pediatr Otorhinolaryngol. 2014 Jan;78(1):1-4
pubmed: 24290952
Int J Colorectal Dis. 2005 Sep;20(5):466-470
pubmed: 15834612
Am J Surg Pathol. 2001 May;25(5):645-51
pubmed: 11342777
Gut. 2001 Apr;48(4):515-21
pubmed: 11247896
Am J Surg Pathol. 2007 Mar;31(3):410-6
pubmed: 17325483
Biosci Trends. 2018;12(6):620-626
pubmed: 30674762
Hum Mutat. 2004 May;23(5):522
pubmed: 15108286

Auteurs

Piedad Alba-Pavón (P)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.

Itziar Astigarraga (I)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Barakaldo, Spain.
Pediatric Department, Universidad del País Vasco UPV/EHU, Leioa, Spain.

Lide Alaña (L)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.

Isabel Llano-Rivas (I)

Department of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Blanca Gener (B)

Department of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Lorena Mosteiro (L)

Department of Pathology, Hospital Universitario Cruces, Osakidetza, Barakaldo, Spain.

Ricardo López-Almaraz (R)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Barakaldo, Spain.

Aizpea Echebarria-Barona (A)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
Pediatrics Department, Hospital Universitario Cruces, Osakidetza, Barakaldo, Spain.

Olatz Villate (O)

Pediatric Oncology Group, Biobizkaia Health Research Institute, Barakaldo, Spain.

Classifications MeSH